Short Interest in Revolution Medicines, Inc. (NASDAQ:RVMDW) Declines By 91.5%

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the target of a significant drop in short interest during the month of November. As of November 15th, there was short interest totalling 400 shares, a drop of 91.5% from the October 31st total of 4,700 shares. Based on an average trading volume of 35,900 shares, the short-interest ratio is presently 0.0 days.

Revolution Medicines Trading Up 2.6 %

NASDAQ RVMDW traded up $0.01 during trading on Wednesday, reaching $0.40. The company’s stock had a trading volume of 89,430 shares, compared to its average volume of 18,743. Revolution Medicines has a twelve month low of $0.03 and a twelve month high of $1.00. The business’s fifty day moving average price is $0.27 and its 200-day moving average price is $0.18.

About Revolution Medicines

Revolution Medicines, Inc, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies.